Laura Shawver is of Silverback Therapeutics, Inc.. Currently has a direct ownership of 210,346 shares of SBTX, which is worth approximately $0. The most recent transaction as insider was on Dec 04, 2024, when has been sold 14,772 shares (Common Stock) at a price of $13.75 per share, resulting in proceeds of $203,115. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 210K
0% 3M change
0% 12M change
Total Value Held $0

Laura Shawver Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 04 2024
SELL
Open market or private sale
$203,115 $13.75 p/Share
14,772 Reduced 6.56%
210,346 Common Stock
Dec 04 2024
BUY
Exercise of conversion of derivative security
$46,531 $3.15 p/Share
14,772 Added 6.16%
225,118 Common Stock
Dec 03 2024
SELL
Open market or private sale
$1,166,667 $13.26 p/Share
87,984 Reduced 29.49%
210,346 Common Stock
Dec 03 2024
BUY
Exercise of conversion of derivative security
$194,444 $2.21 p/Share
87,984 Added 22.78%
298,330 Common Stock
Dec 02 2024
SELL
Open market or private sale
$1,356,553 $13.95 p/Share
97,244 Reduced 31.61%
210,346 Common Stock
Dec 02 2024
BUY
Exercise of conversion of derivative security
$123,499 $1.27 p/Share
97,244 Added 24.02%
307,590 Common Stock
Sep 01 2023
SELL
Open market or private sale
$771,000 $7.71 p/Share
100,000 Reduced 32.22%
210,346 Common Stock
Sep 01 2023
BUY
Exercise of conversion of derivative security
$127,000 $1.27 p/Share
100,000 Added 24.37%
310,346 Common Stock
Aug 04 2023
SELL
Open market or private sale
$133,412 $7.06 p/Share
18,897 Reduced 8.24%
210,346 Common Stock
Aug 04 2023
BUY
Exercise of conversion of derivative security
$23,999 $1.27 p/Share
18,897 Added 7.62%
229,243 Common Stock
Aug 03 2023
SELL
Open market or private sale
$183,010 $7.01 p/Share
26,107 Reduced 11.04%
210,346 Common Stock
Aug 03 2023
BUY
Exercise of conversion of derivative security
$33,155 $1.27 p/Share
26,107 Added 9.94%
236,453 Common Stock
Aug 02 2023
SELL
Open market or private sale
$257,232 $7.09 p/Share
36,281 Reduced 14.71%
210,346 Common Stock
Aug 02 2023
BUY
Exercise of conversion of derivative security
$46,076 $1.27 p/Share
36,281 Added 12.82%
246,627 Common Stock
Aug 01 2023
SELL
Open market or private sale
$134,560 $7.19 p/Share
18,715 Reduced 8.17%
210,346 Common Stock
Aug 01 2023
BUY
Exercise of conversion of derivative security
$23,768 $1.27 p/Share
18,715 Added 7.55%
229,061 Common Stock
Jul 07 2023
SELL
Open market or private sale
$56,336 $6.36 p/Share
8,858 Reduced 4.04%
210,346 Common Stock
Jul 07 2023
BUY
Exercise of conversion of derivative security
$11,249 $1.27 p/Share
8,858 Added 3.88%
219,204 Common Stock
Jul 06 2023
SELL
Open market or private sale
$212,453 $6.34 p/Share
33,510 Reduced 13.74%
210,346 Common Stock
Jul 06 2023
BUY
Exercise of conversion of derivative security
$42,557 $1.27 p/Share
33,510 Added 12.08%
243,856 Common Stock
Jul 05 2023
SELL
Open market or private sale
$199,427 $6.41 p/Share
31,112 Reduced 12.89%
210,346 Common Stock
Jul 05 2023
BUY
Exercise of conversion of derivative security
$39,512 $1.27 p/Share
31,112 Added 11.41%
241,458 Common Stock
Jul 03 2023
SELL
Open market or private sale
$178,214 $6.72 p/Share
26,520 Reduced 11.2%
210,346 Common Stock
Jul 03 2023
BUY
Exercise of conversion of derivative security
$33,680 $1.27 p/Share
26,520 Added 10.07%
236,866 Common Stock
Jun 02 2023
SELL
Open market or private sale
$187,239 $6.95 p/Share
26,941 Reduced 11.35%
210,346 Common Stock

Also insider at

RLAY
Relay Therapeutics, Inc. Healthcare
NKTX
Nkarta, Inc. Healthcare
LS

Laura Shawver

Seattle, WA

Track Institutional and Insider Activities on SBTX

Follow Silverback Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SBTX shares.

Notify only if

Insider Trading

Get notified when an Silverback Therapeutics, Inc. insider buys or sells SBTX shares.

Notify only if

News

Receive news related to Silverback Therapeutics, Inc.

Track Activities on SBTX